These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2428739)

  • 1. SDS denaturation of complement factor C3 as a model for allosteric modifications occurring during C3b binding: demonstration of a profound conformational change by means of circular dichroism and quantitative immunoprecipitation.
    Nilsson B; Nilsson UR
    Immunol Lett; 1986 Aug; 13(1-2):11-4. PubMed ID: 2428739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An assessment of the extent of antigenic analogy between physiologically bound C3 and C3 denatured by sodium dodecyl sulphate.
    Nilsson B; Nilsson UR
    Scand J Immunol; 1985 Dec; 22(6):703-10. PubMed ID: 2418495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analogous antigenic alterations elicited in C3 by physiologic binding and by denaturation in the presence of sodium dodecylsulfate.
    Nilsson UR; Nilsson B
    J Immunol; 1982 Dec; 129(6):2594-7. PubMed ID: 6183339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of multiple fluid-phase C3b:plasma protein complexes during complement activation: possible implications in C3 glomerulopathies.
    Ramadass M; Ghebrehiwet B; Smith RJ; Kew RR
    J Immunol; 2014 Feb; 192(3):1220-30. PubMed ID: 24367026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleophilic modification of human complement protein C3: correlation of conformational changes with acquisition of C3b-like functional properties.
    Isenman DE; Kells DI; Cooper NR; Müller-Eberhard HJ; Pangburn MK
    Biochemistry; 1981 Jul; 20(15):4458-67. PubMed ID: 7284336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of mouse monoclonal antibodies that detect distinct neoantigenic epitopes on bound C3b and iC3b but not on the corresponding soluble fragments.
    Nilsson B; Svensson KE; Borwell P; Nilsson UR
    Mol Immunol; 1987 May; 24(5):487-94. PubMed ID: 2443836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational changes accompanying proteolytic cleavage of human complement protein C3b by the regulatory enzyme factor I and its cofactor H. Spectroscopic and enzymological studies.
    Isenman DE
    J Biol Chem; 1983 Apr; 258(7):4238-44. PubMed ID: 6220003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.
    Laursen SB; Thiel S; Teisner B; Holmskov U; Wang Y; Sim RB; Jensenius JC
    Immunology; 1994 Apr; 81(4):648-54. PubMed ID: 7518801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of antisera to the isolated alpha and beta subunits of C3 as probes to study functional sites present on particle-bound C3b but absent on native soluble forms of C3.
    Whaley K; Nilsson U
    Int Arch Allergy Appl Immunol; 1988; 86(1):55-61. PubMed ID: 2453474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structure of complement C3b provides insights into complement activation and regulation.
    Abdul Ajees A; Gunasekaran K; Volanakis JE; Narayana SV; Kotwal GJ; Murthy HM
    Nature; 2006 Nov; 444(7116):221-5. PubMed ID: 17051152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-enzymic activation of the covalent binding reaction of the complement protein C3.
    Law SK
    Biochem J; 1983 May; 211(2):381-9. PubMed ID: 6870837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
    Medicus RG; Melamed J; Arnaout MA
    Eur J Immunol; 1983 Jun; 13(6):465-70. PubMed ID: 6222909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the thioester bond in C3 and C4 in the determination of the conformational and functional states of the molecule.
    Isenman DE
    Ann N Y Acad Sci; 1983; 421():277-90. PubMed ID: 6202198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products.
    Farries TC; Lachmann PJ; Harrison RA
    Biochem J; 1988 May; 252(1):47-54. PubMed ID: 3421908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation and dissociation of rice ribulose-1,5-bisphosphate carboxylase/oxygenase during denaturation by sodium dodecyl sulfate.
    Lu W; Li S; Li GF; Gong YD; Zhao NM; Zhang RX; Zhou HM
    Biochemistry (Mosc); 2002 Aug; 67(8):940-4. PubMed ID: 12223095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native C3 does not bind to the C3b receptor (CR1) of human blood B lymphocytes or alter immunoglobulin synthesis.
    Berger M; Fleisher TA
    J Immunol; 1983 Mar; 130(3):1021-3. PubMed ID: 6600466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The requirement of localized, CR2-mediated, alternative pathway activation of complement for covalent deposition of C3 fragments on normal B cells.
    Olesen EH; Johnson AA; Damgaard G; Leslie RG
    Immunology; 1998 Feb; 93(2):177-83. PubMed ID: 9616366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of fluid-phase complement components C3 and C3b to human lymphocytes.
    Sim E; Sim RB
    Biochem J; 1981 Sep; 198(3):509-18. PubMed ID: 7326019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoantigens in complement component C3 as detected by monoclonal antibodies. Mapping of the recognized epitopes by synthetic peptides.
    Nilsson B; Nilsson Ekdahl K; Avila D; Nilsson UR; Lambris JD
    Biochem J; 1990 May; 268(1):55-61. PubMed ID: 1693076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amidation of C3 at the thiolester site: stimulation of chemiluminescence and phagocytosis by a new inflammatory mediator.
    Gordon DL; Krueger RA; Quie PG; Hostetter MK
    J Immunol; 1985 May; 134(5):3339-45. PubMed ID: 3980996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.